Search
Search Funnelback University
- Refined by:
- Format: pdf
Your query has been expanded to TALK:PC53 20 |u:www.enterprize.cam.ac.uk. Search for TALK:PC53 20 |u:www.enterprise.cam.ac.uk instead.
11 -
20 of
36
search results for TALK:PC53 20 |u:www.enterprise.cam.ac.uk or TALK:PC53 20 |u:www.enterprize.cam.ac.uk
where 0
match all words and 36
match some words.
Results that match 1 of 2 words
-
Innovation.Partnership.Impact. ANNUAL REVIEW 2023 The University of…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2024/03/CE_Annual_Report23_WEB.pdf26 Mar 2024: 18 NuQuantum: pioneering Quantum Networking for transformative computing. 20 Establishing a home-grown, inclusive innovation roadmap to prosperity for Greater Cambridge. ... 06 OCTOBER. 20 MARCH. £29.8bn economic impact of the University of Cambridge -
Potential uses: • High throughput drug screening for therapeutic ...
https://www.enterprise.cam.ac.uk/wp-content/uploads/2011/09/Sin-2591-11V6_29052019.pdf29 May 2019: display contractile ability in response to carbachol treatment. There was a 10-20% change of surface area in contracting cells. -
patent process
https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/patent-application-process.pdf7 Jul 2015: 0 months. Monopoly for 20 years from filing. 6 months 12 months 18 months 24 months 30 months 5 years. -
PowerPoint Presentation
https://www.enterprise.cam.ac.uk/wp-content/uploads/2020/04/Cambridge-Enterprise-Virus-Research-Reagents.pdf28 Apr 2020: 2009, 90,1202. J Virol. 2010, 84(20), 10937. 2. Herpes Simplex Virus Type 1 and 2 (HSV-1 and -2) antibodies. -
Cambridge innovation in numbersThe University sits at the heart ...
https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/06/innovation_in_numbers_december_2021_2.pdf22 Dec 2021: 92%Of Cambridge Enterprise portfolio companies have a 5-year survival rate. £107.3m In translational research funding won with the support of Cambridge Enterprise 2011-20. -
Annual Review2020 /Where ideas thrive 2 Cambridge Enterprise Annual…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/01/Cambridge-Enterprise-Annual-Review-2020.pdf12 Mar 2021: £2bn. 4 Cambridge Enterprise Annual Review 2020. Some 20,000 people in Botswana are hearing impaired. ... 2019–20 £’000. 2018–19£’000. Investment in IP assets (patent and proof of concept) (1,075) (803). -
Annual Review 2015 Cambridge Enterprise LimitedUniversity of…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/Annual_Report_v21_040116_screen.pdf4 Jan 2016: 20), taking viewers beyond the licences, patents and investments we oversee to illuminate the real-world impact of the research we support. ... Total expenditure (30,146) (18,880). Net income/(expenditure) for the year (156) (20). -
Annual Review 2016 111 In 2006 Cambridge Enterprise Limited ...
https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/2016_Annual_Report_corrected.pdf6 Mar 2017: Dr Mahadeva, Consultant Respiratory Physician at Addenbrooke’s Hospital (Director of Cambridge Antitrypsin Centre), Associate Lecturer, University of Cambridge, has a 20 year interest in AAT. ... The business of company creation. Spin-outs and start-ups -
UK University Technology Transfer: behind the headlinesA note from ...
https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/05/behind-the-headlines.pdf8 May 2015: A recent UK review suggested that these stakes range from 20-67% in the UK and 5-100% in the US. -
UK University Technology Transfer: behind the headlinesA note from ...
https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/Behind-the-headlines.pdf8 May 2015: A recent UK review suggested that these stakes range from 20-67% in the UK and 5-100% in the US.
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.